Results

Total Results: 2,890 records

Showing results for "disease".

281. Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/gerd-2005
     December 13, 2005 - Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease … Archived Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease

282. Disposition of Comments Report for Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-kidney-disease-anemia-2011_disposition-comments.pdf
     January 01, 2011 - Report for Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease … Review Title: Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease … Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease. … Patients with Anemia. " The Report is particularly timely since the Kidney Disease Improving Global … Outcomes (KDIGO) Clinical Practice Guideline for Anemia in Chronic Kidney Disease, which covers many

283. Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/copd-management
     December 04, 2009 - Mortality Risk in Chronic Obstructive Pulmonary Disease Patients Using Theophylline Timeline … 04, 2009 Research Report Mortality Risk in Chronic Obstructive Pulmonary Disease

284. Summary Variables in Observational Research:Propensity Scores and Disease Risk Scores | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/observational-research-scores
     May 15, 2012 - Summary Variables in Observational Research:Propensity Scores and Disease Risk Scores Timeline … Research Report Summary Variables in Observational Research: Propensity Scores and Disease

285. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cad-women-treatment-future
     February 07, 2013 - Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs Timeline … Systematic Review Archived Treatment Strategies for Women With Coronary Artery Disease

286. Comparative Effectiveness of Anticholinergic Medications in Patients with Chronic Obstructive Pulmonary Disease (COPD) | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/copd-anticholinergic-medicines
     December 04, 2009 - Comparative Effectiveness of Anticholinergic Medications in Patients with Chronic Obstructive Pulmonary Disease … Archived Outcomes Associated With Tiotropium use in Chronic Obstructive Pulmonary Disease

287. Enzyme-Replacement Therapies for Lysosomal Storage Diseases | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/lysosomal-storage-diseases-therapies/technical-brief
     January 02, 2013 - Brief May. 2, 2013 Disposition of Comments Report Enzyme-Replacement Therapies for Lysosomal Storage Diseases … Structured Abstract Background Lysosomal storage diseases (LSDs) comprise about 50 unique monogenic … autosomal or X-linked diseases with an estimated combined incidence of 1 in 7,000 to 8,000 live births … LSD management traditionally involved supportive care measures tailored to disease stage, the organs … They include disease-specific intermediate outcomes, such as plasma or urinary levels of macromolecular

288. Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/uterine-fibroids-2010
     March 10, 2011 - Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease … Identification of Future Research Needs in the Comparative Management of Uterine Fibroid Disease

289. Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cad-women-diagnosis-future
     February 07, 2013 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs … Systematic Review Archived Noninvasive Technologies for the Diagnosis of Coronary Artery Disease

290. Research on the Clinical Effectiveness and Long-term Outcomes of Cardiac Implants for Aortic Valve Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cardiac-implants-effectiveness
     March 28, 2013 - Research on the Clinical Effectiveness and Long-term Outcomes of Cardiac Implants for Aortic Valve Disease … Research on the Clinical Effectiveness and Long-term Outcomes of Cardiac Implants for Aortic Valve Disease

291. Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease – An Update to the 2005 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/gerd
     September 23, 2011 - Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease – An Update to … Archived Comparative Effectiveness of Management Strategies for Gastroesophageal Reflux Disease

292. Data Points #4: Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/erythropoiesis-stimulating-agents-utilization
     March 31, 2011 - Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease … Trends in the utilization of erythropoiesis-stimulating agents among Medicare beneficiaries with kidney disease

293. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
     November 01, 2010 - First, CKD shares many of the same risk factors as other vascular diseases, such as older age, hypertension … Causes of CKD can be broken down into primary kidney diseases (predominantly glomerular diseases, tubulointerstitial … diseases, obstruction, and polycystic kidney disease) versus those in which the kidney damage is secondary … (e.g., coronary artery disease [CAD], peripheral arterial disease [PAD], cerebrovascular disease [CVD … and kidney disease.

294. Future Research Needs for the Comparison of Percutaneous Coronary Interventions With Bypass Graft Surgery in Nonacute Coronary Artery Disease | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cad-pci-bypass-future
     September 24, 2010 - Comparison of Percutaneous Coronary Interventions With Bypass Graft Surgery in Nonacute Coronary Artery Disease … Comparison of Percutaneous Coronary Interventions With Bypass Graft Surgery in Nonacute Coronary Artery Disease

295. Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-function
     June 13, 2013 - Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease … Archived Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease

296. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
     August 11, 2014 - Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease … Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease. … to the severity of chronic kidney disease or is there a threshold effect? … Is this due to kidney disease alone? Does this portend increased cardiovascular risk? … Many studies did not adjust for age, history of coronary artery disease, comorbidities, etc.

297. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR " … [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR " … '/exp OR 'ischemic heart disease'/exp OR cad OR 'coronary artery disease' OR 'coronary disease' OR ' … , peripheral vascular disease, diabetes, chronic kidney disease, or congestive heart failure. … ICD-9 (International Classification of Diseases, Ninth Revision) and CPT (Current Procedural Terminology

298. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
     July 01, 2017 - Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Omega-3 Fatty Acids and … Cardiovascular Disease: Current State of the Evidence Focus of This Summary This is a summary of … Heart and Blood Vessel Conditions Heart Disease Background The first observation of a link between … Source The information in this summary is based on Omega-3 Fatty Acids and Cardiovascular Disease: An … Effects of omega-3 fatty acids on cardiovascular disease.

299. My nomination is about comparing outcomes of different glaucoma treatments, particularly canaloplasty to trabeculectomy and to medical therapy alone. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/my-nomination-is-about-comparing-outcomes-of-different-glaucoma-treatments-particularly-canaloplasty-to-trabeculectomy-and-to-medical-therapy-alone
     November 23, 2008 - (you may select more than one category if appropriate)   My question relates to a very common disease … or problem   People with this disease or problem have considerable health or financial hardships   There … or condition:   Screening or diagnosis/identification for a particular disease, or risk assessment for … a disease   Risks or harms that can come from a disease identification tool or test   Diagnostic tests … and tools   Diagnosis of co-occurring diseases   Intervention (such as a drug treatment, therapy, device

300. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/04_dementia_potential_high_impact_june_2012.pdf
     January 01, 2012 - fatal, patients can live as long as 20 years after diagnosis and often have coexisting age-related diseases … regression or slowing of disease progression. … Mild Cognitive Impairment (MCI) due to Alzheimer's Disease Workgroup. … Alzheimer's disease fact sheet. [internet]. … Memory and insulin in early Alzheimer's disease (MAIN).